Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	3421897	3421897	A	G	exonic	MEGF6	.	nonsynonymous SNV	MEGF6:NM_001409:exon17:c.T2063C:p.L688P	4.42E-15	0.994620434	0.005379566	.	0.11042	0.09881	2.072624965	97.81198396	6730.46373	17.39874	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.237	0.158	N	1	0.090	P	-1.3	0.007	N	2.57	0.136	T	5.68	0.000	N	0.032	0.452	-0.927	0.446	T	0.000	0.000	T	.	.	.	-0.904	0.036	0.025	0.046	0.000	0.007	0.029	N	c	-1.324	-1.215	1.000	0.500	0.507	0.198	0	2.53	0.295	1.398	0.339	0.076	0.183	0.004	0.165	0.070	0.176	8.044	0.295	EGF-like domain|EGF-like, conserved site|Growth factor receptor cysteine-rich domain|Laminin EGF domain;Laminin EGF domain	.	.	0.5	153	160	chr1	3421897	chr1:3421897	A	G	153	PASS	AN=2;DP=160	GT	0/1
chr1	12943200	12943200	A	G	exonic	PRAMEF4	.	nonsynonymous SNV	PRAMEF4:NM_001009611:exon2:c.T16C:p.W6R	0.074609525	0.872447591	0.052942885	.	0.14569	.	3.532159363	99.48100967	1356.98129	6.91114	0.789	0.032	T	0.0	0.026	B	0.0	0.013	B	0.008	0.012	N	1	0.090	N	-1.55	0.005	N	3.63	0.044	T	2.01	0.004	N	0.151	0.214	-0.956	0.400	T	0.006	0.020	T	.	.	.	-2.243	0.005	0.001	0.154	0.004	0.000	0.001	N	c	-1.633	-1.642	0.000	0.012	0.487	0.133	0	0.538	0.163	-1.922	0.016	-0.986	0.023	0.000	0.063	0.000	0.016	4.042	0.092	.	.	.	0.5	106	136	chr1	12943200	chr1:12943200	A	G	106	PASS	AN=2;DP=136	GT	0/1
chr1	16890428	16890428	T	A	UTR3	NBPF1	NM_017940:c.*10A>T	.	.	.	.	.	.	.	.	.	.	10963.86792	22.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	336	chr1	16890428	chr1:16890428	T	A	106	PASS	AN=2;DP=336	GT	0/1
chr1	16910040	16910040	A	G	intronic	NBPF1	.	.	.	.	.	.	.	.	.	.	.	10963.86792	22.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	173	2016	chr1	16910040	chr1:16910040	A	G	173	PASS	AN=2;DP=2016	GT	0/1
chr1	16952267	16952267	T	C	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	321	chr1	16952267	chr1:16952267	T	C	128	PASS	AN=2;DP=321	GT	0/1
chr1	16958694	16958694	G	A	intergenic	CROCCP2;MST1P2	dist=1293;dist=13375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	355	chr1	16958694	chr1:16958694	G	A	.	PASS	AN=0;DP=355	GT	0/1
chr1	16959834	16959834	G	T	intergenic	CROCCP2;MST1P2	dist=2433;dist=12235	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	1078	chr1	16959834	chr1:16959834	G	T	130	PASS	AN=2;DP=1078	GT	0/1
chr1	17085030	17085030	C	T	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon11:c.G1445A:p.R482H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	795	chr1	17085030	chr1:17085030	C	T	.	PASS	AN=0;DP=795	GT	0/1
chr1	17087459	17087459	A	G	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon2:c.T206C:p.M69T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	1675	chr1	17087459	chr1:17087459	A	G	156	PASS	AN=2;DP=1675	GT	0/1
chr1	17266609	17266609	G	-	intronic	CROCC	.	.	.	4.71E-20	0.643040868	0.356959132	.	.	0.15832	2.431142199	98.53149328	3783.54242	12.05321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	423	chr1	17266608	chr1:17266608	TG	T	159	PASS	AN=2;DP=423	GT	0/1
chr1	17266616	17266616	A	G	intronic	CROCC	.	.	.	4.71E-20	0.643040868	0.356959132	.	.	0.15832	2.431142199	98.53149328	3783.54242	12.05321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	157	400	chr1	17266616	chr1:17266616	A	G	157	PASS	AN=2;DP=400	GT	0/1
chr1	26671575	26671575	A	G	exonic	CRYBG2	.	nonsynonymous SNV	CRYBG2:NM_001039775:exon2:c.T1574C:p.F525S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	P	.	.	.	.	.	.	.	.	.	0.042	0.022	.	.	.	.	.	.	.	.	.	-0.331	0.066	0.563	0.341	0.021	0.001	0.007	N	n	-0.405	0.161	0.107	0.165	0.078	0.016	0	-2.25	0.065	-0.405	0.072	-1.200	0.016	0.000	0.063	0.000	0.016	5.118	0.141	Ricin B, lectin domain	ENSG00000130695.9|ENSG00000130695.9|ENSG00000130695.9|ENSG00000130695.9	Esophagus_Gastroesophageal_Junction|Esophagus_Muscularis|Lung|Thyroid	0.5	137	177	chr1	26671575	chr1:26671575	A	G	137	PASS	AN=2;DP=177	GT	0/1
chr1	144811965	144811965	C	G	intronic	NBPF19;NBPF20;NBPF8;NBPF9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	338	chr1	144811965	chr1:144811965	C	G	104	PASS	AN=2;DP=338	GT	0/1
chr1	145281656	145281656	A	T	exonic	NOTCH2NL	.	nonsynonymous SNV	NOTCH2NL:NM_203458:exon4:c.A586T:p.T196S	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	0.998	0.764	D	0.987	0.759	D	.	.	.	0.985	0.247	N	1.315	0.329	L	-0.19	0.659	T	.	.	.	0.3	0.360	0.007	0.824	D	0.739	0.911	D	.	.	.	3.920	0.528	23.5	0.992	0.544	0.974	0.740	D	c	0.504	0.409	1.000	0.747	0.675	0.547	0	2.87	0.324	9.118	0.936	0.785	0.317	1.000	0.715	0.992	0.562	9.174	0.361	EGF-like domain	.	.	0.5	117	284	chr1	145281656	chr1:145281656	A	T	117	PASS	AN=2;DP=284	GT	0/1
chr1	148009507	148009507	C	T	intronic	NBPF19;NBPF26	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	120	chr1	148009507	chr1:148009507	C	T	96	PASS	AN=2;DP=120	GT	0/1
chr1	149676264	149676264	T	C	ncRNA_intronic	LOC101929798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	979	chr1	149676264	chr1:149676264	T	C	130	PASS	AN=2;DP=979	GT	0/1
chr1	150526044	150526044	G	C	exonic	ADAMTSL4	.	nonsynonymous SNV	ADAMTSL4:NM_001288607:exon6:c.G577C:p.A193P,ADAMTSL4:NM_001288608:exon6:c.G577C:p.A193P,ADAMTSL4:NM_019032:exon6:c.G577C:p.A193P,ADAMTSL4:NM_025008:exon6:c.G577C:p.A193P	7.09E-16	0.34016242	0.65983758	DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10654	0.09865	-0.00377668	53.51497995	1103.99507	6.3513	0.703	0.076	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-0.205	0.041	N	0.23	0.631	T	1.43	0.011	N	0.012	0.003	-1.058	0.123	T	0.031	0.132	T	.	.	.	-1.198	0.025	0.007	0.673	0.081	0.006	0.026	N	c	-1.688	-1.744	1.000	0.747	0.660	0.495	0	-4.57	0.032	-1.171	0.032	-1.198	0.016	0.000	0.063	0.007	0.100	3.170	0.061	.	ENSG00000143452.11|ENSG00000259357.1|ENSG00000163131.6|ENSG00000259357.1|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143452.11|ENSG00000143369.10|ENSG00000259357.1|ENSG00000163131.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000237781.2|ENSG00000143382.9|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143457.6|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000259357.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Tibial|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Cells_EBV-transformed_lymphocytes|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Spleen|Thyroid|Thyroid|Whole_Blood	0.5	174	195	chr1	150526044	chr1:150526044	G	C	174	PASS	AN=2;DP=195	GT	0/1
chr1	153516163	153516163	A	-	UTR3	S100A4	NM_019554:c.*72delT;NM_002961:c.*72delT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	303	chr1	153516162	chr1:153516162	GA	G,GAA	59	PASS	AN=2;DP=303	GT	0/1
chr1	153516163	153516163	-	A	UTR3	S100A4	NM_019554:c.*71_*72insT;NM_002961:c.*71_*72insT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	303	chr1	153516162	chr1:153516162	GA	G,GAA	59	PASS	AN=2;DP=303	GT	0/1
chr1	161595981	161595981	C	T	exonic	FCGR3B	.	synonymous SNV	FCGR3B:NM_001244753:exon4:c.G639A:p.G213G,FCGR3B:NM_001271035:exon4:c.G636A:p.G212G,FCGR3B:NM_001271036:exon4:c.G480A:p.G160G,FCGR3B:NM_000570:exon5:c.G531A:p.G177G	3.30E-05	0.35412722	0.645839759	.	0.00848	0.09063	-0.115612493	45.12856806	161.44959	2.77603	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	133	chr1	161595981	chr1:161595981	C	T	.	PASS	AN=0;DP=133	GT	0/1
chr1	201178768	201178768	A	G	exonic	IGFN1	.	nonsynonymous SNV	IGFN1:NM_001164586:exon12:c.A4747G:p.S1583G	2.50E-18	0.007485788	0.992514212	.	0.12425	0.10243	6.487063031	99.87615004	12297.47943	23.82839	0.621	0.053	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	-1.03	0.764	T	0.67	0.023	N	0.016	0.013	-1.014	0.258	T	0.146	0.471	T	0.069	0.706	D	-2.098	0.007	0.001	0.770	0.113	0.001	0.004	N	c	-1.686	-1.819	0.000	0.035	0.487	0.133	0	-1.87	0.073	-1.095	0.034	-3.069	0.001	0.000	0.063	0.000	0.016	0.803	0.010	.	.	.	0.5	157	480	chr1	201178768	chr1:201178768	A	G	157	PASS	AN=2;DP=480	GT	0/1
chr1	201178984	201178984	G	A	exonic	IGFN1	.	nonsynonymous SNV	IGFN1:NM_001164586:exon12:c.G4963A:p.G1655S	2.50E-18	0.007485788	0.992514212	.	0.12425	0.10243	6.487063031	99.87615004	12297.47943	23.82839	0.016	0.518	D	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	-2.97	0.920	D	-0.61	0.181	N	0.042	0.022	-0.619	0.641	T	0.419	0.765	T	.	.	.	0.205	0.114	4.733	0.981	0.379	0.045	0.100	N	c	-0.942	-1.104	0.000	0.029	0.487	0.133	0	-2.16	0.066	0.171	0.164	0.670	0.294	0.000	0.063	0.005	0.090	4.275	0.102	.	.	.	0.5	115	692	chr1	201178984	chr1:201178984	G	A	115	PASS	AN=2;DP=692	GT	0/1
chr1	207888640	207888640	-	T	intronic	CR1L	.	.	.	3.56E-15	0.020225564	0.979774436	.	0.06963	.	3.872389272	99.64614296	2178.56335	8.59961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	211	chr1	207888640	chr1:207888640	C	CT	78	PASS	AN=2;DP=211	GT	0/1
chr1	236899900	236899900	C	-	exonic	ACTN2	.	frameshift deletion	ACTN2:NM_001278344:exon10:c.91delC:p.P32Lfs*11	0.999811916	0.000188084	7.39E-12	DISEASE: Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:20022194, ECO:0000269|PubMed:25173926}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:14567970, ECO:0000269|PubMed:25224718}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.77327	0.39885	-1.723336008	2.465204058	447.74179	4.40066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	79	chr1	236899899	chr1:236899899	TC	T	152	PASS	AN=2;DP=79	GT	0/1
chr1	242383170	242383170	-	AC	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	54	chr1	242383170	chr1:242383170	T	TAC	118	PASS	AN=2;DP=54	GT	0/1
chr1	248436857	248436857	C	T	exonic	OR2T33	.	nonsynonymous SNV	OR2T33:NM_001004695:exon1:c.G260A:p.S87N	0.016492203	0.706716697	0.2767911	.	0.10124	0.09346	1.219937511	93.19414956	662.98621	5.16078	0.399	0.105	T	0.0	0.026	B	0.0	0.013	B	0.481	0.122	N	1	0.090	N	0.1	0.085	N	4.08	0.030	T	0.88	0.017	N	0.039	0.023	-0.925	0.449	T	0.000	0.000	T	.	.	.	-1.390	0.020	0.003	0.413	0.029	0.002	0.009	N	c	-1.759	-1.873	0.000	0.063	0.487	0.133	0	-5.39	0.024	-2.295	0.012	-0.142	0.109	0.000	0.063	0.001	0.043	1.568	0.024	GPCR, rhodopsin-like, 7TM	.	.	0.5	118	570	chr1	248436857	chr1:248436857	C	T	118	PASS	AN=2;DP=570	GT	0/1
chr2	15536509	15536509	-	A	intronic	NBAS	.	.	.	1.89E-25	0.999906723	9.33E-05	DISEASE: Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]: A form of infantile liver failure syndrome, a life-threatening disorder of hepatic function that manifests with acute liver failure in the first few months of life. Clinical features include anemia, renal tubulopathy, developmental delay, seizures, failure to thrive, and liver steatosis and fibrosis. {ECO:0000269|PubMed:26073778}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=NBAS mutations have been found in a multisystem disease affecting the liver, eye, immune system, connective tissue, and bone. Clinical manifestations include a progeroid appearance, short stature, slender bones, epiphyseal dysplasia with multiple phalangeal pseudo-epiphyses, cervical instability, myelopathy, elevated transaminases, hypogammaglobulinemia, reduced natural killer cells, Pelger-Huet anomaly of granulocytes, and in some cases retinal dystrophy and optic atrophy. {ECO:0000269|PubMed:26286438}.; 	.	.	-0.224542487	37.33191791	2659.86206	9.69933	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	42	chr2	15536509	chr2:15536509	G	GA	79	PASS	AN=2;DP=42	GT	0/1
chr2	23792485	23792485	-	T	intronic	KLHL29	.	.	.	.	.	.	.	0.74488	.	-0.53631094	20.53550366	164.66985	2.80262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	41	chr2	23792485	chr2:23792485	A	AT	109	PASS	AN=2;DP=41	GT	0/1
chr2	71658541	71658541	C	T	exonic	ZNF638	.	nonsynonymous SNV	ZNF638:NM_001014972:exon26:c.C5735T:p.A1912V,ZNF638:NM_001252612:exon26:c.C5735T:p.A1912V,ZNF638:NM_001252613:exon26:c.C5735T:p.A1912V,ZNF638:NM_014497:exon26:c.C5735T:p.A1912V	0.99995995	4.01E-05	5.79E-17	.	0.53078	0.09373	-1.600473032	3.01958009	4929.35469	14.30986	0.484	0.081	T	0.017	0.163	B	0.003	0.080	B	0.163	0.031	N	1	0.090	P	1.1	0.281	L	1.47	0.320	T	0.1	0.058	N	0.003	0.000	-1.049	0.147	T	0.001	0.002	T	.	.	.	3.047	0.426	22.4	0.978	0.357	0.237	0.219	N	c	-0.755	-0.678	0.158	0.175	0.707	0.730	0	1.86	0.244	1.021	0.294	-0.375	0.066	0.520	0.269	0.111	0.193	4.368	0.106	.	ENSG00000205847.5	Esophagus_Mucosa	0.5	164	194	chr2	71658541	chr2:71658541	C	T	164	PASS	AN=2;DP=194	GT	0/1
chr2	87169455	87169455	-	CGGCCTCGACCTGGCGGGGCGG	intronic	RGPD1;RGPD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	328	chr2	87169455	chr2:87169455	A	ACGGCCTCGACCTGGCGGGGCGG	130	PASS	AN=2;DP=328	GT	0/1
chr2	87408300	87408300	G	A	intergenic	LOC285074;MIR4771-2	dist=104764;dist=13609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	90	chr2	87408300	chr2:87408300	G	A	90	PASS	AN=2;DP=90	GT	0/1
chr2	96521280	96521280	T	G	exonic	ANKRD36C	.	nonsynonymous SNV	ANKRD36C:NM_001310154:exon84:c.A5827C:p.I1943L	.	.	.	.	.	.	.	.	2676.37542	9.72635	0.119	0.280	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	2.54	0.139	T	-0.89	0.240	N	0.077	0.068	-0.967	0.377	T	0.013	0.048	T	.	.	.	-0.120	0.083	1.583	0.702	0.089	0.017	0.053	N	c	-1.017	-1.184	0.000	0.035	0.707	0.730	0	-2.62	0.058	-0.723	0.050	-0.461	0.055	0.000	0.063	0.016	0.126	0.732	0.009	.	.	.	0.5	121	489	chr2	96521280	chr2:96521280	T	G	121	PASS	AN=2;DP=489	GT	0/1
chr2	98205924	98205924	C	G	intronic	ANKRD36B	.	.	.	.	.	.	.	0.28221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	241	chr2	98205924	chr2:98205924	C	G	105	PASS	AN=2;DP=241	GT	0/1
chr2	101437601	101437601	C	G	intronic	NPAS2	.	.	.	0.990888562	0.009111438	7.90E-10	.	0.21897	0.22837	-0.506987379	21.76810569	5079.47281	14.59455	.	.	.	0.005	0.119	B	0.003	0.080	B	.	.	.	1	0.090	P	.	.	.	0.78	0.494	T	.	.	.	0.089	0.086	-0.993	0.318	T	0.000	0.000	T	.	.	.	0.932	0.183	10.26	0.684	0.084	0.123	0.170	N	c	-0.944	-0.949	1.000	0.747	0.437	0.062	0	2.43	0.287	0.288	0.186	0.852	0.362	0.003	0.159	0.015	0.124	7.284	0.253	.	ENSG00000170485.12	Skin_Sun_Exposed_Lower_leg	0.5	190	179	chr2	101437601	chr2:101437601	C	G	190	PASS	AN=2;DP=179	GT	1/0
chr2	120714402	120714404	TTT	-	intronic	PTPN4	.	.	.	0.999997516	2.48E-06	3.96E-17	.	0.18506	0.12354	-0.021969881	52.14673272	429.77615	4.32968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.35	98	chr2	120714401	chr2:120714401	CTTT	C,CT,CTTTT	10.35	PASS	AN=0;DP=98	GT	0/1/.
chr2	120714403	120714404	TT	-	intronic	PTPN4	.	.	.	0.999997516	2.48E-06	3.96E-17	.	0.18506	0.12354	-0.021969881	52.14673272	429.77615	4.32968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.35	98	chr2	120714401	chr2:120714401	CTTT	C,CT,CTTTT	10.35	PASS	AN=0;DP=98	GT	0/1/.
chr2	120714404	120714404	-	T	intronic	PTPN4	.	.	.	0.999997516	2.48E-06	3.96E-17	.	0.18506	0.12354	-0.021969881	52.14673272	429.77615	4.32968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.35	98	chr2	120714401	chr2:120714401	CTTT	C,CT,CTTTT	10.35	PASS	AN=0;DP=98	GT	0/1/.
chr2	120857746	120857747	TA	-	intronic	EPB41L5	.	.	.	0.022933841	0.977065093	1.07E-06	.	0.19351	0.09111	0.04598748	57.47817882	253.06645	3.42227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	138	37	chr2	120857745	chr2:120857745	GTA	G	138	PASS	AN=2;DP=37	GT	1/1
chr2	132384704	132384704	T	C	downstream	POTEKP	dist=702	.	.	.	.	.	.	.	0.43916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	717	chr2	132384704	chr2:132384704	T	C	137	PASS	AN=2;DP=717	GT	0/1
chr2	132860647	132860647	C	T	intergenic	LINC01945;ANKRD30BL	dist=65174;dist=44517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	121	chr2	132860647	chr2:132860647	C	T	86	PASS	AN=2;DP=121	GT	0/1
chr2	224620103	224620213	ACTGTCTTTCTCTTGGTAGTTTTATAGTAATTATATAATATAAAGAAAACACAATGACTATTTTAGCCTAGGCCCATGGAAGATGTCCCTAAAATCCCTCAAATTTACCCC	-	UTR3	AP1S3	NM_001039569:c.*3329_*3219delGGGGTAAATTTGAGGGATTTTAGGGACATCTTCCATGGGCCTAGGCTAAAATAGTCATTGTGTTTTCTTTATATTATATAATTACTATAAAACTACCAAGAGAAAGACAGT	.	.	0.167450177	0.771753753	0.06079607	.	0.14506	0.10315	1.302692676	93.93724935	140.64371	2.58746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	318	chr2	224620102	chr2:224620102	TACTGTCTTTCTCTTGGTAGTTTTATAGTAATTATATAATATAAAGAAAACACAATGACTATTTTAGCCTAGGCCCATGGAAGATGTCCCTAAAATCCCTCAAATTTACCCC	T	58	PASS	AN=2;DP=318	GT	0/1
chr2	226265720	226265722	TGG	-	UTR5	NYAP2	NM_020864:c.-7877_-7875del-	.	.	0.906196258	0.093772035	3.17E-05	.	.	.	-0.020150552	52.25288983	158.7708	2.75169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	158	73	chr2	226265719	chr2:226265719	CTGG	C	158	PASS	AN=2;DP=73	GT	1/0
chr2	241808308	241808308	-	C	exonic	AGXT	.	frameshift insertion	AGXT:NM_000030:exon1:c.26dupC:p.K12Qfs*155	0.003594369	0.9539627	0.042442931	DISEASE: Hyperoxaluria primary 1 (HP1) [MIM:259900]: An inborn error of glyoxylate metabolism characterized by increased excretion of oxalate and glycolate, and progressive tissue accumulation of insoluble calcium oxalate. Affected individuals are at risk for nephrolithiasis, nephrocalcinosis and early onset end-stage renal disease. {ECO:0000269|PubMed:10394939, ECO:0000269|PubMed:10453743, ECO:0000269|PubMed:10541294, ECO:0000269|PubMed:10862087, ECO:0000269|PubMed:12559847, ECO:0000269|PubMed:1301173, ECO:0000269|PubMed:1349575, ECO:0000269|PubMed:15253729, ECO:0000269|PubMed:15849466, ECO:0000269|PubMed:15961946, ECO:0000269|PubMed:15963748, ECO:0000269|PubMed:16971151, ECO:0000269|PubMed:1703535, ECO:0000269|PubMed:17495019, ECO:0000269|PubMed:2039493, ECO:0000269|PubMed:23229545, ECO:0000269|PubMed:24055001, ECO:0000269|PubMed:24934730, ECO:0000269|PubMed:26149463, ECO:0000269|PubMed:8101040, ECO:0000269|PubMed:9192270, ECO:0000269|PubMed:9604803}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59321	0.59981	0.644875971	84.10002359	526.88786	4.68568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	818	chr2	241808307	chr2:241808307	AC	ACC,A	86	PASS	AN=2;DP=818	GT	0/1
chr2	241808308	241808308	C	-	exonic	AGXT	.	frameshift deletion	AGXT:NM_000030:exon1:c.26delC:p.K12Rfs*33	0.003594369	0.9539627	0.042442931	DISEASE: Hyperoxaluria primary 1 (HP1) [MIM:259900]: An inborn error of glyoxylate metabolism characterized by increased excretion of oxalate and glycolate, and progressive tissue accumulation of insoluble calcium oxalate. Affected individuals are at risk for nephrolithiasis, nephrocalcinosis and early onset end-stage renal disease. {ECO:0000269|PubMed:10394939, ECO:0000269|PubMed:10453743, ECO:0000269|PubMed:10541294, ECO:0000269|PubMed:10862087, ECO:0000269|PubMed:12559847, ECO:0000269|PubMed:1301173, ECO:0000269|PubMed:1349575, ECO:0000269|PubMed:15253729, ECO:0000269|PubMed:15849466, ECO:0000269|PubMed:15961946, ECO:0000269|PubMed:15963748, ECO:0000269|PubMed:16971151, ECO:0000269|PubMed:1703535, ECO:0000269|PubMed:17495019, ECO:0000269|PubMed:2039493, ECO:0000269|PubMed:23229545, ECO:0000269|PubMed:24055001, ECO:0000269|PubMed:24934730, ECO:0000269|PubMed:26149463, ECO:0000269|PubMed:8101040, ECO:0000269|PubMed:9192270, ECO:0000269|PubMed:9604803}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59321	0.59981	0.644875971	84.10002359	526.88786	4.68568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	818	chr2	241808307	chr2:241808307	AC	ACC,A	86	PASS	AN=2;DP=818	GT	0/1
chr2	242140634	242140671	CAGCTTCCTCCAAACCTTCTGCACCGTTCACATGCCCA	-	intronic	ANO7	.	.	.	1.87E-30	1.93E-05	0.999980702	.	0.10367	0.1057	0.268088483	70.58858221	3536.57926	11.4675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	220	chr2	242140633	chr2:242140633	GCAGCTTCCTCCAAACCTTCTGCACCGTTCACATGCCCA	G	76	PASS	AN=2;DP=220	GT	0/1
chr2	243052762	243052762	T	C	ncRNA_intronic	LINC01881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	150	chr2	243052762	chr2:243052762	T	C	96	PASS	AN=2;DP=150	GT	0/1
chr3	101485483	101485484	AT	-	UTR3	CEP97	NM_024548:c.*1088_*1089delAT;NM_001303401:c.*1088_*1089delAT	.	.	1.33E-06	0.988939885	0.011058789	.	0.39973	0.09879	-0.595174814	18.21184242	175.1978	2.87864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	21	chr3	101485482	chr3:101485482	GAT	G	69	PASS	AN=2;DP=21	GT	0/1
chr3	125643940	125643940	C	G	ncRNA_exonic	FAM86JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	173	1456	chr3	125643940	chr3:125643940	C	G	173	PASS	AN=2;DP=1456	GT	0/1
chr3	138351814	138351814	G	A	exonic	FAIM	.	nonsynonymous SNV	FAIM:NM_001033032:exon5:c.G433A:p.G145R,FAIM:NM_018147:exon5:c.G433A:p.G145R,FAIM:NM_001033030:exon6:c.G535A:p.G179R,FAIM:NM_001033031:exon6:c.G499A:p.G167R	0.068117194	0.871676576	0.06020623	.	0.1045	0.11959	0.170987912	65.5579146	4094.91295	12.69722	0.045	0.408	D	0.21	0.500	B	0.141	0.388	B	0.000	0.843	D	1	0.810	D	2.63	0.772	M	1.52	0.307	T	-5.19	0.836	D	0.633	0.795	-1.001	0.297	T	0.087	0.338	T	0.019	0.415	T	2.877	0.406	21.7	0.984	0.405	0.983	0.813	D	c	0.183	0.175	1.000	0.747	0.706	0.609	0	5.26	0.734	7.560	0.811	1.048	0.713	1.000	0.715	0.553	0.280	16.415	0.835	.	.	.	0.5	52	87	chr3	138351814	chr3:138351814	G	A	52	PASS	AN=2;DP=87	GT	0/1
chr3	186917751	186917751	C	G	exonic	RTP1	.	nonsynonymous SNV	RTP1:NM_153708:exon2:c.C685G:p.Q229E	0.563829726	0.423951854	0.01221842	.	0.79035	0.11684	0.064394823	58.84642604	2341.27335	8.96348	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.003	0.351	N	1	0.090	P	0.55	0.145	N	1.62	0.282	T	-0.48	0.154	N	0.056	0.039	-0.976	0.358	T	0.000	0.000	T	.	.	.	0.084	0.102	3.442	0.622	0.067	0.018	0.056	N	c	-0.780	-0.618	0.910	0.263	0.615	0.372	0	5.74	0.900	1.719	0.374	0.133	0.217	0.528	0.269	0.580	0.285	12.993	0.579	.	ENSG00000198491.3|ENSG00000175077.5	Artery_Aorta|Nerve_Tibial	0.5	142	241	chr3	186917751	chr3:186917751	C	G	142	PASS	AN=2;DP=241	GT	0/1
chr3	195400814	195400814	-	TT	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	305	chr3	195400814	chr3:195400814	C	CTT	103	PASS	AN=2;DP=305	GT	0/1
chr4	15724487	15724487	T	G	intronic	BST1	.	.	.	2.81E-08	0.291985673	0.708014299	.	0.1269	0.19823	0.861712133	88.6883699	1705.28413	7.61637	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	43	chr4	15724487	chr4:15724487	T	G	87	PASS	AN=2;DP=43	GT	0/1
chr4	141294814	141294814	G	C	exonic	SCOC	.	nonsynonymous SNV	SCOC:NM_001153484:exon1:c.G124C:p.V42L,SCOC:NM_001153552:exon1:c.G124C:p.V42L,SCOC:NM_001153663:exon1:c.G124C:p.V42L	0.280616506	0.631537689	0.087845805	.	0.3001	0.11229	0.701931997	85.34442085	698.26576	5.26029	0.036	0.433	D	0.001	0.067	B	0.001	0.040	B	0.167	0.031	N	1	0.197	P	1.04	0.263	L	.	.	.	-0.37	0.132	N	0.164	0.198	-1.089	0.057	T	0.000	0.001	T	.	.	.	1.962	0.297	15.98	0.586	0.059	0.236	0.219	N	c	-0.773	-0.755	1.000	0.747	0.442	0.072	0	3.31	0.369	1.416	0.341	1.048	0.713	0.007	0.175	0.003	0.074	6.448	0.209	.	ENSG00000153132.8|ENSG00000153132.8	Esophagus_Mucosa|Muscle_Skeletal	0.5	182	301	chr4	141294814	chr4:141294814	G	C	182	PASS	AN=2;DP=301	GT	0/1
chr4	146080578	146080578	T	-	UTR3	OTUD4	NM_017493:c.*73delA	.	.	0.999916478	8.35E-05	2.07E-13	.	0.46205	0.12897	-0.993849454	8.56334041	130.30354	2.48591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	23	chr4	146080577	chr4:146080577	AT	A	51	PASS	AN=2;DP=23	GT	0/1
chr4	190878577	190878577	A	G	exonic	FRG1	.	nonsynonymous SNV	FRG1:NM_004477:exon6:c.A457G:p.N153D	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	0.004	0.654	D	0.481	0.349	P	0.6	0.489	P	0.000	0.843	D	1.000	0.588	D	2.56	0.750	M	1.75	0.505	T	-4.0	0.769	D	0.204	0.530	-0.731	0.589	T	0.247	0.616	T	.	.	.	4.427	0.593	24.2	0.993	0.572	0.982	0.800	D	c	0.095	0.054	1.000	0.427	0.707	0.730	0	2.99	0.335	7.501	0.803	0.136	0.221	1.000	0.715	0.992	0.562	8.215	0.305	Actin cross-linking	.	.	0.5	114	211	chr4	190878577	chr4:190878577	A	G	114	PASS	AN=2;DP=211	GT	0/1
chr5	840704	840704	G	A	exonic	ZDHHC11	.	synonymous SNV	ZDHHC11:NM_024786:exon5:c.C690T:p.T230T	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	895	chr5	840704	chr5:840704	G	A	109	PASS	AN=2;DP=895	GT	0/1
chr5	10390429	10390429	T	-	intronic	MARCH6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	289	chr5	10390428	chr5:10390428	CT	C,CTT	75	PASS	AN=2;DP=289	GT	0/1
chr5	10390429	10390429	-	T	intronic	MARCH6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	289	chr5	10390428	chr5:10390428	CT	C,CTT	75	PASS	AN=2;DP=289	GT	0/1
chr5	140563616	140563616	G	A	exonic	PCDHB16	.	synonymous SNV	PCDHB16:NM_020957:exon1:c.G1482A:p.Q494Q	0.001770815	0.897216857	0.101012328	.	0.07988	0.19766	1.072886248	91.70794999	8831.34731	20.28873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	311	chr5	140563616	chr5:140563616	G	A	.	PASS	AN=0;DP=311	GT	0/1
chr5	180055849	180055849	T	G	intronic	FLT4	.	.	.	0.999936679	6.33E-05	4.32E-15	DISEASE: Lymphedema, hereditary, 1A (LMPH1A) [MIM:153100]: A chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment. {ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:10856194, ECO:0000269|PubMed:16924388, ECO:0000269|PubMed:16965327, ECO:0000269|PubMed:17458866, ECO:0000269|PubMed:19289394, ECO:0000269|PubMed:26091405, ECO:0000269|PubMed:9817924}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:11807987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=Plays an important role in tumor lymphangiogenesis, in cancer cell survival, migration, and formation of metastases.; 	0.19958	0.23555	0.707220641	85.53314461	835.41804	5.65903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	176	chr5	180055849	chr5:180055849	T	G	149	PASS	AN=2;DP=176	GT	0/1
chr6	3157731	3157731	C	G	UTR5	TUBB2A	NM_001310315:c.-2552G>C;NM_001069:c.-34G>C	.	.	.	.	.	DISEASE: Cortical dysplasia, complex, with other brain malformations 5 (CDCBM5) [MIM:615763]: A disorder of aberrant neuronal migration and disturbed axonal guidance. Clinical features include seizures, global developmental delay, and various brain malformations such as a diffuse simplified gyral pattern with reduced volume of white matter, globular basal ganglia, thin and dysmorphic corpus callosum, mild brainstem hypoplasia with a flat pons, mild cerebellar vermis hypoplasia, and mildly enlarged posterior fossa. {ECO:0000269|PubMed:24702957}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87839	0.33588	-0.119252484	44.53880632	2.40691	0.08385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	276	chr6	3157731	chr6:3157731	C	G	124	PASS	AN=2;DP=276	GT	0/1
chr6	15468723	15468729	GGGTGAG	-	intronic	JARID2	.	.	.	0.999862193	0.000137807	7.01E-13	.	0.98339	0.18221	-1.741783094	2.418023119	264.05908	3.48721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	44	chr6	15468722	chr6:15468722	AGGGTGAG	A	118	PASS	AN=2;DP=44	GT	0/1
chr7	912131	912131	G	A	exonic	SUN1	.	nonsynonymous SNV	SUN1:NM_001171944:exon16:c.G1864A:p.E622K,SUN1:NM_025154:exon17:c.G1924A:p.E642K,SUN1:NM_001130965:exon18:c.G2173A:p.E725K	0.835840781	0.164158985	2.34E-07	.	0.12582	0.08767	0.834017099	88.13989148	1176.18927	6.51539	0.002	0.721	D	0.955	0.764	P	0.69	0.722	P	0.000	0.843	D	1	0.810	D	2.23	0.633	M	1.04	0.402	T	-3.42	0.687	D	0.315	0.689	-0.576	0.658	T	0.317	0.687	T	0.017	0.380	T	5.959	0.819	27.7	0.999	0.992	0.990	0.904	D	c	0.410	0.482	1.000	0.747	0.707	0.730	0	5.07	0.680	6.520	0.735	1.048	0.713	1.000	0.715	0.999	0.750	18.789	0.919	SUN domain	.	.	0.5	.	81	chr7	912131	chr7:912131	G	A	.	PASS	AN=0;DP=81	GT	0/1
chr7	1474669	1474669	C	T	intronic	MICALL2	.	.	.	7.76E-17	0.004116347	0.995883653	.	0.27411	0.08337	1.39439264	94.65675867	907.55182	5.86145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	789	chr7	1474669	chr7:1474669	C	T	72	PASS	AN=2;DP=789	GT	0/1
chr7	26576535	26576535	T	C	ncRNA_exonic	KIAA0087	.	.	.	.	.	.	.	.	.	.	.	17.91578	0.62616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	92	chr7	26576535	chr7:26576535	T	C	150	PASS	AN=2;DP=92	GT	0/1
chr7	64672804	64672804	A	G	ncRNA_exonic	INTS4P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	104	chr7	64672804	chr7:64672804	A	G	137	PASS	AN=2;DP=104	GT	0/1
chr7	76069902	76069902	G	C	exonic	ZP3	.	nonsynonymous SNV	ZP3:NM_001110354:exon7:c.G1034C:p.R345T,ZP3:NM_007155:exon8:c.G881C:p.R294T	0.001596815	0.88505152	0.113351664	.	0.2396	0.20208	0.775339069	87.13729653	870.97448	5.74737	0.263	0.164	T	0.002	0.197	B	0.004	0.176	B	0.499	0.120	U	1	0.090	N	1.175	0.300	L	2.41	0.252	T	-2.4	0.527	N	0.034	0.346	-0.987	0.332	T	0.030	0.131	T	.	.	.	-1.381	0.020	0.003	0.447	0.034	0.042	0.097	N	c	-1.589	-1.705	0.999	0.386	0.644	0.439	0	-8.56	0.008	-0.279	0.084	-0.405	0.062	0.000	0.063	0.000	0.016	12.211	0.535	Zona pellucida domain	.	.	0.5	93	52	chr7	76069902	chr7:76069902	G	C	93	PASS	AN=2;DP=52	GT	0/1
chr7	128033797	128033797	G	A	intronic	IMPDH1	.	.	.	0.005811859	0.993226508	0.000961634	DISEASE: Retinitis pigmentosa 10 (RP10) [MIM:180105]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:11875049, ECO:0000269|PubMed:11875050, ECO:0000269|PubMed:16384941}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leber congenital amaurosis 11 (LCA11) [MIM:613837]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:16384941}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69586	0.09849	-0.244249595	36.17008728	74.88549	1.81072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	987	chr7	128033797	chr7:128033797	G	A	83	PASS	AN=2;DP=987	GT	0/1
chr7	143453661	143453661	T	G	exonic	CTAGE6	.	nonsynonymous SNV	CTAGE6:NM_178561:exon1:c.A1091C:p.E364A	0.366836245	0.621526849	0.011636907	.	.	.	.	.	126.17664	2.44439	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	.	.	.	-3	0.000	N	3.5	0.050	T	.	.	.	0.041	0.021	.	.	.	.	.	.	.	.	.	-1.880	0.010	0.002	0.508	0.044	0.000	0.003	N	n	-0.640	-0.258	0.000	0.012	0.075	0.013	0	0.109	0.138	-0.293	0.083	-0.934	0.025	0.493	0.267	0.028	0.145	.	.	.	.	.	0.5	.	120	chr7	143453661	chr7:143453661	T	G	.	PASS	AN=0;DP=120	GT	0/1
chr7	151936982	151936982	C	A	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	51	chr7	151936982	chr7:151936982	C	A	59	PASS	AN=2;DP=51	GT	0/1
chr7	151970705	151970705	A	C	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	104	chr7	151970705	chr7:151970705	A	C	86	PASS	AN=2;DP=104	GT	0/1
chr7	151970859	151970859	C	T	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon7:c.G943A:p.G315S	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.068	0.357	T	1.0	0.899	D	1.0	0.971	D	0.000	0.454	D	1.000	0.588	D	2.28	0.651	M	-0.67	0.725	T	-4.31	0.782	D	0.637	0.654	0.272	0.871	D	0.583	0.850	D	.	.	.	7.435	0.951	34	0.997	0.794	0.978	0.767	D	c	0.865	0.801	1.000	0.747	0.693	0.553	0	4.87	0.627	7.809	0.845	0.935	0.490	1.000	0.715	0.624	0.293	18.375	0.903	Zinc finger, PHD-type	.	.	0.5	100	224	chr7	151970859	chr7:151970859	C	T	100	PASS	AN=2;DP=224	GT	0/1
chr8	7218752	7218752	G	C	exonic	ZNF705G	.	nonsynonymous SNV	ZNF705G:NM_001164457:exon2:c.C19G:p.L7V	4.25E-09	0.029374202	0.970625794	.	.	.	.	.	148.15733	2.652	1.0	0.010	T	.	.	.	.	.	.	.	.	.	1	0.090	P	-0.835	0.015	N	5.86	0.007	T	1.95	0.004	N	0.023	0.008	-0.978	0.354	T	0.000	0.000	T	.	.	.	-1.536	0.016	0.002	0.347	0.021	0.000	0.003	N	c	-1.649	-1.680	0.833	0.247	0.598	0.340	0	1.24	0.203	-0.336	0.078	-0.597	0.044	0.002	0.151	0.132	0.200	2.834	0.051	Krueppel-associated box	.	.	0.5	92	43	chr8	7218752	chr8:7218752	G	C	92	PASS	AN=2;DP=43	GT	0/1
chr8	38876466	38876466	T	C	intronic	ADAM9	.	.	.	0.828249261	0.171750686	5.34E-08	.	0.23427	0.21827	-0.201976964	38.98325077	410.4595	4.24565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	37	chr8	38876466	chr8:38876466	T	C	80	PASS	AN=2;DP=37	GT	0/1
chr8	100874068	100874068	G	T	exonic	VPS13B	.	synonymous SNV	VPS13B:NM_017890:exon58:c.G11184T:p.L3728L,VPS13B:NM_152564:exon58:c.G11109T:p.L3703L	9.81E-27	0.999999996	3.72E-09	.	0.28405	0.17647	-0.610811433	17.50412833	5683.91051	15.59736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	458	chr8	100874068	chr8:100874068	G	T	155	PASS	AN=2;DP=458	GT	0/1
chr8	124822508	124822508	T	-	intronic	FAM91A1	.	.	.	0.515693527	0.484306207	2.67E-07	.	0.30469	.	-0.622676946	17.30950696	54.36063	1.47405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	141	chr8	124822507	chr8:124822507	CT	C	114	PASS	AN=2;DP=141	GT	0/1
chr8	127153830	127153830	G	C	intergenic	LINC00861;LOC101927657	dist=190389;dist=183910	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	163	chr8	127153830	chr8:127153830	G	C	77	PASS	AN=2;DP=163	GT	0/1
chr8	128428462	128428462	C	-	exonic	POU5F1B	.	frameshift deletion	POU5F1B:NM_001159542:exon1:c.351delC:p.P119Lfs*3	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	1373	chr8	128428461	chr8:128428461	TC	T	97	PASS	AN=2;DP=1373	GT	0/1
chr8	131072825	131072825	C	A	exonic	ASAP1	.	synonymous SNV	ASAP1:NM_018482:exon28:c.G3192T:p.T1064T,ASAP1:NM_001247996:exon29:c.G3171T:p.T1057T	0.999983091	1.69E-05	8.56E-16	.	0.41578	0.17656	-1.240018202	5.461193678	937.06285	5.93485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	390	chr8	131072825	chr8:131072825	C	A	.	PASS	AN=0;DP=390	GT	0/1
chr8	143425267	143425267	C	-	intronic	TSNARE1	.	.	.	3.60E-07	0.792734251	0.207265389	.	0.13119	0.10131	1.050838371	91.36588818	5557.39016	15.40816	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	863	chr8	143425266	chr8:143425266	GC	G	99	PASS	AN=2;DP=863	GT	0/1
chr8	144464706	144464706	C	G	exonic	RHPN1	.	nonsynonymous SNV	RHPN1:NM_052924:exon15:c.C1898G:p.P633R	1.30E-06	0.822567716	0.177430984	.	0.10052	0.10074	-0.529034136	20.85987261	149.9984	2.67044	0.003	0.682	D	0.998	0.715	D	0.962	0.690	D	0.004	0.348	N	0.827	0.348	D	1.83	0.482	L	0.45	0.565	T	-2.55	0.551	D	0.669	0.679	-0.489	0.691	T	0.246	0.615	T	0.053	0.653	D	4.491	0.601	24.3	0.997	0.825	0.164	0.192	N	c	0.097	-0.050	0.998	0.368	0.696	0.567	0	3.89	0.439	-0.180	0.097	0.852	0.362	0.000	0.063	0.438	0.260	9.219	0.363	.	.	.	0.5	112	551	chr8	144464706	chr8:144464706	C	G	112	PASS	AN=2;DP=551	GT	0/1
chr8	144808652	144808652	G	A	exonic	FAM83H	.	synonymous SNV	FAM83H:NM_198488:exon5:c.C2979T:p.N993N	0.88482471	0.115121211	5.41E-05	.	0.27378	0.10604	.	.	1586.01963	7.36593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	chr8	144808652	chr8:144808652	G	A	.	PASS	AN=0;DP=118	GT	0/1
chr8	145110662	145110662	C	T	intronic	OPLAH	.	.	.	2.99E-11	0.887670231	0.112329769	DISEASE: 5-oxoprolinase deficiency (OPLAHD) [MIM:260005]: A disorder characterized by calcium oxalate/carbonate urolithiasis, and excessive urinary 5-oxo-L-proline. Affected individuals have recurrent episodes of vomiting, diarrhea, and abdominal pain. {ECO:0000269|PubMed:21651516}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11816	0.18621	.	.	2315.28938	8.91132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	488	chr8	145110662	chr8:145110662	C	T	96	PASS	AN=2;DP=488	GT	0/1
chr9	117371	117371	C	G	exonic	FOXD4	.	nonsynonymous SNV	FOXD4:NM_207305:exon1:c.G749C:p.G250A	.	.	.	.	0.15599	.	0.885576705	89.14248644	2757.82566	9.90294	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-1.385	0.006	N	-3.38	0.942	D	0.03	0.066	N	0.045	0.025	-0.991	0.323	T	0.000	0.000	T	.	.	.	-2.220	0.005	0.001	0.636	0.071	0.002	0.009	N	c	-1.644	-1.642	0.010	0.120	0.598	0.340	0	0.496	0.160	0.134	0.156	-0.054	0.122	0.000	0.063	0.003	0.074	4.257	0.101	.	ENSG00000172785.14|ENSG00000170122.4|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14	Adipose_Subcutaneous|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Transverse|Esophagus_Mucosa|Heart_Atrial_Appendage|Lung|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid	0.5	170	294	chr9	117371	chr9:117371	C	G	170	PASS	AN=2;DP=294	GT	0/1
chr9	9425588	9425588	-	ACTT	intronic	PTPRD	.	.	.	0.999999982	1.80E-08	4.88E-23	.	0.89661	0.17382	-3.078871465	0.483604624	1565.5627	7.32256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	48	chr9	9425588	chr9:9425588	C	CACTT	85	PASS	AN=2;DP=48	GT	0/1
chr9	33401246	33401246	G	A	exonic	AQP7	.	synonymous SNV	AQP7:NM_001170:exon2:c.C15T:p.S5S,AQP7:NM_001318158:exon2:c.C15T:p.S5S	1.86E-09	0.034706833	0.965293165	.	0.0624	0.1324	0.108486928	61.90728946	500.92929	4.59263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	254	chr9	33401246	chr9:33401246	G	A	91	PASS	AN=2;DP=254	GT	0/1
chr9	66513792	66513792	C	G	ncRNA_exonic	LOC403323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	283	chr9	66513792	chr9:66513792	C	G	135	PASS	AN=2;DP=283	GT	0/1
chr9	66553447	66553447	G	C	ncRNA_exonic	LOC403323;LOC728673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	289	chr9	66553447	chr9:66553447	G	C	129	PASS	AN=2;DP=289	GT	0/1
chr9	68429152	68429152	T	C	ncRNA_exonic	FRG1JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	198	chr9	68429152	chr9:68429152	T	C	140	PASS	AN=2;DP=198	GT	0/1
chr9	70871836	70871836	C	G	splicing	CBWD3	NM_201453:exon5:c.431-1C>G	.	.	0.358916975	0.589020154	0.052062871	.	.	0.09807	.	.	7163.3464	18.21502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	67	chr9	70871836	chr9:70871836	C	G	128	PASS	AN=2;DP=67	GT	0/1
chr10	30978164	30978164	A	G	intergenic	LYZL2;SVILP1	dist=59517;dist=3039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	150	chr10	30978164	chr10:30978164	A	G	109	PASS	AN=2;DP=150	GT	0/1
chr10	52445761	52445761	A	T	intergenic	SGMS1-AS1;ASAH2B	dist=54365;dist=53687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	232	chr10	52445761	chr10:52445761	A	T	131	PASS	AN=2;DP=232	GT	0/1
chr10	98510642	98510642	G	A	intergenic	PIK3AP1;MIR607	dist=30363;dist=77784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	107	chr10	98510642	chr10:98510642	G	A	65	PASS	AN=2;DP=107	GT	0/1
chr10	114154662	114154662	-	T	intronic	ACSL5	.	.	.	0.016763711	0.983194812	4.15E-05	.	0.14592	0.15681	0.268267497	70.64166077	551.73015	4.77877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	66	chr10	114154662	chr10:114154662	G	GT	93	PASS	AN=2;DP=66	GT	0/1
chr11	2329988	2329988	C	T	exonic	TSPAN32	.	nonsynonymous SNV	TSPAN32:NM_139022:exon4:c.C302T:p.A101V	0.000537261	0.88875402	0.110708719	.	0.07365	.	0.376678994	75.50719509	156.95947	2.73665	0.917	0.040	T	0.425	0.336	B	0.106	0.296	B	0.120	0.027	N	1	0.242	N	-0.975	0.012	N	-1.1	0.773	T	0.45	0.032	N	0.115	0.492	-0.877	0.500	T	0.142	0.463	T	0.052	0.651	D	-0.186	0.077	1.175	0.214	0.008	0.014	0.047	N	c	-1.742	-1.817	0.791	0.240	0.403	0.052	0	-5.48	0.024	-2.393	0.011	-0.641	0.041	0.000	0.063	0.016	0.126	5.543	0.162	.	.	.	0.5	81	767	chr11	2329988	chr11:2329988	C	T	81	PASS	AN=2;DP=767	GT	0/1
chr11	6644619	6644619	G	C	exonic	DCHS1	.	stopgain	DCHS1:NM_003737:exon21:c.C8288G:p.S2763X	0.999995438	4.56E-06	5.90E-20	DISEASE: Mitral valve prolapse 2 (MVP2) [MIM:607829]: A form of mitral valve prolapse, a valvular hearth disease characterized by abnormally elongated and thickened mitral valve leaflets, that typically show myxomatous degeneration with increased leaflet compliance. It is associated with mitral regurgitation. Myxomatous mitral valves have an abnormal layered architecture characterized by loose collagen in fibrosa, expanded spongiosa strongly positive for proteoglycans, and disrupted elastin in atrialis. In classic mitral valve prolapse, leaflets are at least 5 mm thick, whereas in the non-classic form, they are less than 5 mm thick. Severe classic mitral valve prolapse is strongly associated with arrhythmias, endocarditis, heart failure, and need for valve surgery. {ECO:0000269|PubMed:26258302}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.32953	0.13101	-1.375261521	4.399622552	2403.94476	9.1039	.	.	.	.	.	.	.	.	.	0.005	0.331	N	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.753	0.993	43	0.995	0.657	0.908	0.520	D	c	0.853	0.723	1.000	0.500	0.707	0.730	0	5.15	0.702	2.421	0.441	1.048	0.713	1.000	0.715	1.000	0.888	14.137	0.647	Cadherin|Cadherin-like	.	.	0.5	101	113	chr11	6644619	chr11:6644619	G	C	101	PASS	AN=2;DP=113	GT	0/1
chr11	12525925	12525925	C	T	exonic	PARVA	.	synonymous SNV	PARVA:NM_018222:exon6:c.C726T:p.R242R	0.34376402	0.655640245	0.000595734	.	0.24069	0.17061	-0.405853867	26.23260203	31.71128	0.99845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	65	chr11	12525925	chr11:12525925	C	T	118	PASS	AN=2;DP=65	GT	0/1
chr11	14535216	14535217	AC	-	exonic	PSMA1	.	frameshift deletion	PSMA1:NM_002786:exon7:c.443_444del:p.C148Sfs*3,PSMA1:NM_148976:exon8:c.461_462del:p.C154Sfs*3	0.947988405	0.051976702	3.49E-05	.	0.94257	0.50622	-0.229483771	36.86010852	24.18661	0.7943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	283	chr11	14535215	chr11:14535215	GAC	G	67	PASS	AN=2;DP=283	GT	0/1
chr11	19735241	19735241	G	A	ncRNA_exonic	LOC100126784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	182	chr11	19735241	chr11:19735241	G	A	.	PASS	AN=0;DP=182	GT	0/1
chr11	64880312	64880312	G	C	exonic	TM7SF2	.	nonsynonymous SNV	TM7SF2:NM_001277233:exon3:c.G279C:p.K93N,TM7SF2:NM_003273:exon3:c.G279C:p.K93N	0.000447934	0.964092177	0.035459889	.	0.09798	.	-0.380166007	27.88393489	2447.70004	9.20626	0.091	0.318	T	0.002	0.090	B	0.013	0.154	B	0.001	0.412	D	1	0.810	D	0.055	0.082	N	-4.54	0.990	D	1.13	0.020	N	0.098	0.153	0.613	0.921	D	0.852	0.951	D	0.128	0.811	D	3.585	0.488	23.2	0.989	0.474	0.924	0.553	D	c	-0.197	0.014	1.000	0.747	0.652	0.477	0	4.77	0.603	3.746	0.546	0.974	0.594	1.000	0.715	0.998	0.697	13.165	0.588	.	.	.	0.5	147	191	chr11	64880312	chr11:64880312	G	C	147	PASS	AN=2;DP=191	GT	0/1
chr11	65315391	65315391	C	G	exonic	LTBP3	.	nonsynonymous SNV	LTBP3:NM_001130144:exon12:c.G1846C:p.D616H,LTBP3:NM_001164266:exon12:c.G1495C:p.D499H,LTBP3:NM_021070:exon12:c.G1846C:p.D616H	0.996034359	0.003965641	1.03E-10	DISEASE: Dental anomalies and short stature (DASS) [MIM:601216]: A disorder characterized by hypoplastic amelogenesis imperfecta, significant short stature, brachyolmia-like anomalies including platyspondyly with short pedicles, narrow intervertebral and interpedicular distances, rectangular-shaped vertebrae with posterior scalloping and herniation of the nuclei, and broad femoral necks. Dental anomalies include widely spaced, small, yellow teeth, oligodontia, and severely reduced to absent enamel. {ECO:0000269|PubMed:19344874}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30397	0.12827	-0.93133804	9.613116301	914.10791	5.87861	0.001	0.784	D	0.998	0.899	D	0.947	0.971	D	0.000	0.447	D	1	0.810	D	3.245	0.900	M	-5.39	0.991	D	-6.17	0.902	D	0.48	0.582	-0.092	0.803	T	0.429	0.772	T	0.666	0.972	D	5.222	0.705	25.6	0.993	0.588	0.960	0.667	D	c	0.621	0.520	1.000	0.747	0.707	0.730	0	4.7	0.586	4.344	0.589	0.808	0.332	0.999	0.424	0.965	0.450	15.11	0.719	EGF-like calcium-binding domain|EGF-like calcium-binding, conserved site|EGF-like domain|Growth factor receptor cysteine-rich domain	.	.	0.5	100	1263	chr11	65315391	chr11:65315391	C	G	100	PASS	AN=2;DP=1263	GT	0/1
chr11	68133035	68133035	T	C	intronic	LRP5	.	.	.	0.99835557	0.00164443	2.44E-12	DISEASE: Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:15024691, ECO:0000269|PubMed:15346351, ECO:0000269|PubMed:15981244, ECO:0000269|PubMed:16929062, ECO:0000269|PubMed:19324841, ECO:0000269|PubMed:20340138, ECO:0000269|PubMed:24715757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. {ECO:0000269|PubMed:14727154, ECO:0000269|PubMed:15824851, ECO:0000269|PubMed:16234968}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]: A disease characterized by congenital or infancy-onset blindness and severe juvenile-onset osteoporosis and spontaneous fractures. Additional clinical manifestations may include microphthalmos, abnormalities of the iris, lens or vitreous, cataracts, short stature, microcephaly, ligamental laxity, mental retardation and hypotonia. {ECO:0000269|PubMed:11719191, ECO:0000269|PubMed:16252235, ECO:0000269|PubMed:16679074, ECO:0000269|PubMed:17437160, ECO:0000269|PubMed:18602879}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: High bone mass trait (HBM) [MIM:601884]: Rare phenotype characterized by exceptionally dense bones. HBM individuals show otherwise a completely normal skeletal structure and no other unusual clinical findings. {ECO:0000269|PubMed:11741193, ECO:0000269|PubMed:12015390, ECO:0000269|PubMed:15824861, ECO:0000269|PubMed:17295608}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Endosteal hyperostosis, Worth type (WENHY) [MIM:144750]: An autosomal dominant sclerosing bone dysplasia clinically characterized by elongation of the mandible, increased gonial angle, flattened forehead, and the presence of a slowly enlarging osseous prominence of the hard palate (torus palatinus). Serum calcium, phosphorus and alkaline phosphatase levels are normal. Radiologically, it is characterized by early thickening of the endosteum of long bones, the skull and of the mandible. With advancing age, the trabeculae of the metaphysis become thickened. WENHY becomes clinically and radiologically evident by adolescence, does not cause deformity except in the skull and mandible, and is not associated with bone pain or fracture. Affected patients have normal height, proportion, intelligence and longevity. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteopetrosis, autosomal dominant 1 (OPTA1) [MIM:607634]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. OPTA1 is an autosomal dominant form characterized by generalized osteosclerosis most pronounced in the cranial vault. Patients are often asymptomatic, but some suffer from pain and hearing loss. It appears to be the only type of osteopetrosis not associated with an increased fracture rate. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Van Buchem disease 2 (VBCH2) [MIM:607636]: VBCH2 is an autosomal dominant sclerosing bone dysplasia characterized by cranial osteosclerosis, thickened calvaria and cortices of long bones, enlarged mandible and normal serum alkaline phosphatase levels. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07666	0.10394	-3.724445291	0.241802312	2445.60749	9.20072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	184	135	chr11	68133035	chr11:68133035	T	C	184	PASS	AN=2;DP=135	GT	1/0
chr11	71507205	71507205	C	T	exonic	FAM86C1	.	nonsynonymous SNV	FAM86C1:NM_152563:exon3:c.C302T:p.P101L,FAM86C1:NM_001099653:exon4:c.C383T:p.P128L,FAM86C1:NM_018172:exon4:c.C404T:p.P135L	1.48E-08	0.031767811	0.968232174	.	0.09393	.	0.505321956	80.00707714	5743.67103	15.72823	1.0	0.044	T	0.0	0.067	B	0.0	0.013	B	.	.	.	1.000	0.090	N	.	.	.	2.38	0.158	T	-0.88	0.238	N	0.278	0.336	-1.010	0.268	T	0.000	0.000	T	.	.	.	-0.567	0.052	0.150	0.859	0.157	0.003	0.015	N	c	-1.780	-1.907	0.006	0.111	0.706	0.609	0	-2.98	0.051	-2.252	0.013	-0.390	0.064	0.000	0.063	0.016	0.126	1.306	0.019	.	.	.	0.5	123	436	chr11	71507205	chr11:71507205	C	T	123	PASS	AN=2;DP=436	GT	0/1
chr11	71507232	71507232	C	G	ncRNA_intronic	ALG1L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	160	446	chr11	71507232	chr11:71507232	C	G	160	PASS	AN=2;DP=446	GT	0/1
chr11	71507261	71507261	A	G	ncRNA_intronic	ALG1L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	191	404	chr11	71507261	chr11:71507261	A	G	191	PASS	AN=2;DP=404	GT	0/1
chr11	120008373	120008373	C	T	exonic	TRIM29	.	nonsynonymous SNV	TRIM29:NM_012101:exon1:c.G367A:p.E123K	9.17E-05	0.934953701	0.064954626	.	0.50874	0.11722	-0.064242613	48.844067	476.53225	4.50967	0.005	0.632	D	0.826	0.439	P	0.137	0.317	B	0.042	0.239	N	0.727	0.337	D	1.78	0.463	L	0.97	0.425	T	-0.55	0.168	N	0.114	0.138	-1.082	0.070	T	0.063	0.263	T	0.050	0.640	D	3.334	0.459	22.9	0.994	0.644	0.891	0.491	D	c	0.022	0.088	1.000	0.747	0.497	0.185	0	5.06	0.677	1.534	0.354	0.892	0.403	0.670	0.281	0.921	0.396	14.095	0.644	.	.	.	0.5	51	360	chr11	120008373	chr11:120008373	C	T	51	PASS	AN=2;DP=360	GT	0/1
chr11	123893791	123893791	A	C	exonic	OR10G9	.	synonymous SNV	OR10G9:NM_001001953:exon1:c.A72C:p.P24P	0.007138452	0.531885237	0.460976311	.	0.05817	0.09497	3.688480395	99.5576787	1919.79326	8.06598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	453	chr11	123893791	chr11:123893791	A	C	149	PASS	AN=2;DP=453	GT	0/1
chr12	9452017	9452017	C	A	ncRNA_exonic	LOC642846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	165	491	chr12	9452017	chr12:9452017	C	A	165	PASS	AN=2;DP=491	GT	0/1
chr12	52912805	52912805	C	T	exonic	KRT5	.	nonsynonymous SNV	KRT5:NM_000424:exon2:c.G695A:p.S232N	0.469327658	0.529553221	0.001119121	DISEASE: Epidermolysis bullosa simplex, Dowling-Meara type (DM- EBS) [MIM:131760]: A severe form of intraepidermal epidermolysis bullosa characterized by generalized herpetiform blistering, milia formation, dystrophic nails, and mucous membrane involvement. {ECO:0000269|PubMed:10730767, ECO:0000269|PubMed:12655565, ECO:0000269|PubMed:1372711, ECO:0000269|PubMed:16786515, ECO:0000269|PubMed:16882168, ECO:0000269|PubMed:21623745, ECO:0000269|PubMed:8757772, ECO:0000269|PubMed:9036937, ECO:0000269|PubMed:9406827, ECO:0000269|PubMed:9989794, ECO:0000269|Ref.16}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, with migratory circinate erythema (EBSMCE) [MIM:609352]: A form of intraepidermal epidermolysis bullosa characterized by unusual migratory circinate erythema. Skin lesions appear from birth primarily on the hands, feet, and legs but spare nails, ocular epithelia and mucosae. Lesions heal with brown pigmentation but no scarring. Electron microscopy findings are distinct from those seen in the DM-EBS, with no evidence of tonofilament clumping. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, Weber-Cockayne type (WC- EBS) [MIM:131800]: A form of intraepidermal epidermolysis bullosa characterized by blistering limited to palmar and plantar areas of the skin. {ECO:0000269|PubMed:10782015, ECO:0000269|PubMed:12655565, ECO:0000269|PubMed:12707098, ECO:0000269|PubMed:14723728, ECO:0000269|PubMed:15140024, ECO:0000269|PubMed:15347343, ECO:0000269|PubMed:16786515, ECO:0000269|PubMed:16882168, ECO:0000269|PubMed:21623745, ECO:0000269|PubMed:7506097, ECO:0000269|PubMed:7520042, ECO:0000269|PubMed:7688477, ECO:0000269|PubMed:8595431, ECO:0000269|PubMed:8807337, ECO:0000269|PubMed:9804357}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, Koebner type (K-EBS) [MIM:131900]: A form of intraepidermal epidermolysis bullosa characterized by generalized skin blistering. The phenotype is not fundamentally distinct from the Dowling-Meara type, although it is less severe. {ECO:0000269|PubMed:11407988, ECO:0000269|PubMed:11973334, ECO:0000269|PubMed:16882168, ECO:0000269|PubMed:21623745, ECO:0000269|PubMed:7534039, ECO:0000269|PubMed:7686424, ECO:0000269|PubMed:9740251, ECO:0000269|PubMed:9989794}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, with mottled pigmentation (MP-EBS) [MIM:131960]: A form of intraepidermal epidermolysis bullosa characterized by blistering at acral sites and 'mottled' pigmentation of the trunk and proximal extremities with hyper- and hypopigmentation macules. {ECO:0000269|PubMed:10494094, ECO:0000269|PubMed:16882168, ECO:0000269|PubMed:21623745, ECO:0000269|PubMed:8799157}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dowling-Degos disease 1 (DDD1) [MIM:179850]: An autosomal dominant genodermatosis. Affected individuals develop a postpubertal reticulate hyperpigmentation that is progressive and disfiguring, and small hyperkeratotic dark brown papules that affect mainly the flexures and great skin folds. Patients usually show no abnormalities of the hair or nails. {ECO:0000269|PubMed:16465624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78233	0.59494	0.117584698	62.19037509	1967.54739	8.174	0.196	0.207	T	0.097	0.240	B	0.058	0.250	B	0.912	0.074	N	1	0.090	N	0.93	0.236	L	-2.38	0.883	D	-0.92	0.262	N	0.468	0.519	-0.570	0.660	T	0.494	0.808	T	0.058	0.671	D	-0.300	0.068	0.663	0.892	0.180	0.094	0.150	N	c	-0.855	-0.868	1.000	0.489	0.487	0.133	0	2.35	0.280	-0.042	0.119	0.852	0.362	0.000	0.063	0.059	0.170	8.049	0.296	.	.	.	0.5	.	208	chr12	52912805	chr12:52912805	C	T	.	PASS	AN=0;DP=208	GT	0/1
chr12	68946720	68946720	C	T	intergenic	LINC02384;RAP1B	dist=101456;dist=57899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	81	chr12	68946720	chr12:68946720	C	T	121	PASS	AN=2;DP=81	GT	0/1
chr12	123687774	123687774	C	T	intronic	MPHOSPH9	.	.	.	0.000759987	0.999233869	6.14E-06	.	0.16591	0.08911	-0.214928658	37.7388535	739.49466	5.39891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	49	chr12	123687774	chr12:123687774	C	T	103	PASS	AN=2;DP=49	GT	0/1
chr13	20413021	20413021	T	C	exonic	ZMYM5	.	nonsynonymous SNV	ZMYM5:NM_001039650:exon5:c.A691G:p.T231A,ZMYM5:NM_001142684:exon5:c.A691G:p.T231A	0.200378135	0.7895718	0.010050066	.	0.06748	0.07051	0.485092724	79.37603208	1157.52256	6.47872	0.041	0.477	D	0.048	0.207	B	0.013	0.158	B	0.004	0.342	N	0.999	0.588	P	0	0.065	N	1.01	0.411	T	0.31	0.058	N	0.061	0.109	-1.076	0.081	T	0.000	0.001	T	.	.	.	0.786	0.169	9.378	0.947	0.247	0.822	0.412	D	c	-0.835	-0.761	0.992	0.326	0.732	0.924	0	-0.334	0.120	0.570	0.232	-0.595	0.044	0.996	0.391	0.001	0.043	4.843	0.128	.	ENSG00000196199.9|ENSG00000196199.9|ENSG00000121390.13|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000215572.2|ENSG00000196199.9	Artery_Aorta|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Muscularis|Lung|Muscle_Skeletal|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Stomach|Testis|Thyroid	0.5	94	158	chr13	20413021	chr13:20413021	T	C	94	PASS	AN=2;DP=158	GT	0/1
chr13	49776080	49776080	A	G	exonic	FNDC3A	.	synonymous SNV	FNDC3A:NM_014923:exon22:c.A2964G:p.K988K,FNDC3A:NM_001079673:exon24:c.A3132G:p.K1044K,FNDC3A:NM_001278438:exon24:c.A3132G:p.K1044K	0.999884368	0.000115632	1.87E-14	.	0.44936	0.49287	-1.54691447	3.284972871	365.09768	4.0427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	55	chr13	49776080	chr13:49776080	A	G	88	PASS	AN=2;DP=55	GT	0/1
chr13	113140521	113140521	G	A	intronic	TUBGCP3	.	.	.	0.952526134	0.047473866	3.86E-10	.	0.55085	0.13487	-1.50825116	3.503184713	46.90553	1.32419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr13	113140521	chr13:113140521	G	A	.	PASS	AN=0;DP=66	GT	0/1
chr14	19889580	19889580	-	GGTGGAGCGTGACCGCCTCGCCGC	ncRNA_exonic	BMS1P22	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	119	chr14	19889580	chr14:19889580	G	GGGTGGAGCGTGACCGCCTCGCCGC	132	PASS	AN=2;DP=119	GT	0/1
chr14	21762904	21762904	C	T	exonic	RPGRIP1	.	stopgain	RPGRIP1:NM_020366:exon2:c.C154T:p.R52X	2.57E-21	0.046731913	0.953268087	DISEASE: Leber congenital amaurosis 6 (LCA6) [MIM:613826]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11528500, ECO:0000269|PubMed:18682808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 13 (CORD13) [MIM:608194]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:12920076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous non-synonymous variants of RPGRIP1 may cause or increase the susceptibility to various forms of glaucoma, a genetically heterogeneous disorder. It is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons (PubMed:21224891). {ECO:0000269|PubMed:21224891}.; 	0.0819	0.1823	1.298854499	93.91365888	2951.663	10.29586	.	.	.	.	.	.	.	.	.	0.591	0.110	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.421	0.975	37	0.998	0.892	0.875	0.467	D	c	0.739	0.580	0.417	0.203	0.487	0.133	0	4.52	0.546	4.035	0.568	0.832	0.339	0.998	0.411	0.036	0.153	12.617	0.558	.	.	.	0.5	58	191	chr14	21762904	chr14:21762904	C	T	58	PASS	AN=2;DP=191	GT	0/1
chr14	24470138	24470138	C	T	exonic	DHRS4L2	.	stopgain	DHRS4L2:NM_001193636:exon4:c.C172T:p.R58X,DHRS4L2:NM_198083:exon4:c.C475T:p.R159X,DHRS4L2:NM_001193635:exon5:c.C289T:p.R97X	0.357376762	0.630130113	0.012493125	.	0.03505	0.0907	2.465816951	98.61405992	3973.73722	12.46785	.	.	.	.	.	.	.	.	.	0.000	0.843	D	0.000	0.810	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.590	0.976	37	0.997	0.825	0.706	0.344	D	c	0.417	0.212	0.002	0.088	0.706	0.609	0	2.84	0.321	1.494	0.350	0.715	0.302	1.000	0.715	0.996	0.625	10.151	0.418	NAD(P)-binding domain	ENSG00000187630.10|ENSG00000187630.10|ENSG00000215256.3|ENSG00000157326.14|ENSG00000215256.3|ENSG00000197775.1|ENSG00000225766.4|ENSG00000187630.10|ENSG00000215256.3|ENSG00000157326.14|ENSG00000157326.14|ENSG00000215256.3|ENSG00000197775.1|ENSG00000225766.4|ENSG00000215256.3|ENSG00000197775.1	Adipose_Subcutaneous|Artery_Tibial|Artery_Tibial|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Nerve_Tibial|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Spleen|Testis|Thyroid|Thyroid	0.5	146	179	chr14	24470138	chr14:24470138	C	T	146	PASS	AN=2;DP=179	GT	0/1
chr14	106206603	106206603	A	G	intergenic	ELK2AP;MIR4507	dist=67459;dist=117690	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	166	664	chr14	106206603	chr14:106206603	A	G	166	PASS	AN=2;DP=664	GT	0/1
chr14	106206606	106206606	A	G	intergenic	ELK2AP;MIR4507	dist=67462;dist=117687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	163	658	chr14	106206606	chr14:106206606	A	G	163	PASS	AN=2;DP=658	GT	0/1
chr15	20448169	20448169	A	G	intergenic	NONE;CHEK2P2	dist=NONE;dist=39828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	245	chr15	20448169	chr15:20448169	A	G	66	PASS	AN=2;DP=245	GT	0/1
chr15	23441118	23441118	T	A	ncRNA_exonic	GOLGA8EP	.	.	.	.	.	.	.	0.09256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	152	chr15	23441118	chr15:23441118	T	A	.	PASS	AN=0;DP=152	GT	0/1
chr15	25926186	25926186	G	A	exonic	ATP10A	.	synonymous SNV	ATP10A:NM_024490:exon18:c.C3528T:p.A1176A	0.611013499	0.388986496	5.02E-09	.	0.1176	0.15831	1.291519174	93.86058033	7442.03783	18.53574	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	45	chr15	25926186	chr15:25926186	G	A	65	PASS	AN=2;DP=45	GT	0/1
chr15	25926198	25926198	C	G	exonic	ATP10A	.	nonsynonymous SNV	ATP10A:NM_024490:exon18:c.G3516C:p.W1172C	0.611013499	0.388986496	5.02E-09	.	0.1176	0.15831	1.291519174	93.86058033	7442.03783	18.53574	0.0	0.912	D	1.0	0.899	D	0.984	0.745	D	0.000	0.843	D	0.000	0.588	P	2.985	0.859	M	-0.76	0.734	T	-10.64	0.991	D	0.503	0.548	-0.921	0.454	T	0.007	0.024	T	.	.	.	4.480	0.600	24.2	0.992	0.552	0.990	0.904	D	c	0.726	0.623	1.000	0.747	0.554	0.283	0	4.84	0.620	7.651	0.825	0.852	0.362	1.000	0.715	0.984	0.507	17.938	0.889	P-type ATPase, C-terminal	.	.	0.5	66	36	chr15	25926198	chr15:25926198	C	G	66	PASS	AN=2;DP=36	GT	0/1
chr15	25926204	25926204	C	G	exonic	ATP10A	.	synonymous SNV	ATP10A:NM_024490:exon18:c.G3510C:p.T1170T	0.611013499	0.388986496	5.02E-09	.	0.1176	0.15831	1.291519174	93.86058033	7442.03783	18.53574	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	35	chr15	25926204	chr15:25926204	C	G	65	PASS	AN=2;DP=35	GT	0/1
chr15	29444087	29444087	-	CCC	intronic	FAM189A1	.	.	.	.	.	.	.	.	.	1.460671256	95.18164661	1223.91052	6.61202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	92	chr15	29444087	chr15:29444087	T	TCCC	119	PASS	AN=2;DP=92	GT	0/1
chr15	76074518	76074518	T	G	intergenic	MIR4313;UBE2Q2	dist=19862;dist=61109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	160	161	chr15	76074518	chr15:76074518	T	G	160	PASS	AN=2;DP=161	GT	0/1
chr15	83014106	83014106	T	C	exonic	GOLGA6L10	.	synonymous SNV	GOLGA6L10:NM_001164465:exon6:c.A477G:p.V159V	0.36895894	0.48046894	0.15057212	.	.	.	.	.	738.28141	5.39276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	197	chr15	83014106	chr15:83014106	T	C	72	PASS	AN=2;DP=197	GT	0/1
chr16	242923	242923	C	G	intronic	LUC7L	.	.	.	0.164212797	0.835159363	0.00062784	.	0.53946	0.08557	0.040529541	57.15380986	47.06421	1.32691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	253	chr16	242923	chr16:242923	C	G	83	PASS	AN=2;DP=253	GT	0/1
chr16	15022146	15022146	A	G	ncRNA_intronic	PKD1P3-NPIPA1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	168	1643	chr16	15022146	chr16:15022146	A	G	168	PASS	AN=2;DP=1643	GT	0/1
chr16	18540782	18540782	G	A	intronic	NOMO2	.	.	.	.	.	.	.	.	0.10593	.	.	370.47787	4.06416	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	67	chr16	18540782	chr16:18540782	G	A	58	PASS	AN=2;DP=67	GT	0/1
chr16	25255080	25255080	-	AAAACTCCTTGGTTTTGCACC	intronic	ZKSCAN2	.	.	.	0.002937675	0.996956495	0.00010583	.	0.11037	.	0.343511191	73.73790988	3138.88928	10.66791	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	48	chr16	25255080	chr16:25255080	T	TAAAACTCCTTGGTTTTGCACC	75	PASS	AN=2;DP=48	GT	0/1
chr16	31196420	31196420	C	T	exonic	FUS	.	synonymous SNV	FUS:NM_001170634:exon6:c.C681T:p.G227G,FUS:NM_001170937:exon6:c.C672T:p.G224G,FUS:NM_004960:exon6:c.C684T:p.G228G	0.999963786	3.62E-05	3.26E-12	DISEASE: Note=A chromosomal aberration involving FUS is found in a patient with malignant myxoid liposarcoma. Translocation t(12;16)(q13;p11) with DDIT3. {ECO:0000269|PubMed:7503811}.; DISEASE: Note=A chromosomal aberration involving FUS is a cause of acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with ERG. {ECO:0000269|PubMed:8187069}.; DISEASE: Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A distinct variant of malignant fibrous histiocytoma that typically occurs in children and adolescents and is manifest by nodular subcutaneous growth. Characteristic microscopic features include lobulated sheets of histiocyte-like cells intimately associated with areas of hemorrhage and cystic pseudovascular spaces, as well as a striking cuffing of inflammatory cells, mimicking a lymph node metastasis. {ECO:0000269|PubMed:11063792}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving FUS is found in a patient with angiomatoid fibrous histiocytoma. Translocation t(12;16)(q13;p11.2) with ATF1 generates a chimeric FUS/ATF1 protein. {ECO:0000269|PubMed:11063792}.; DISEASE: Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:19251627, ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:19861302, ECO:0000269|PubMed:20124201}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A common movement disorder mainly characterized by postural tremor of the arms. Head, legs, trunk, voice, jaw, and facial muscles also may be involved. The condition can be aggravated by emotions, hunger, fatigue and temperature extremes, and may cause a functional disability or even incapacitation. Inheritance is autosomal dominant. {ECO:0000269|PubMed:22863194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42621	0.49093	-1.001120478	8.321538099	78.86065	1.87589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	611	chr16	31196420	chr16:31196420	C	T	.	PASS	AN=0;DP=611	GT	0/1
chr16	55866900	55866900	T	C	intronic	CES1	.	.	.	6.77E-14	0.00837054	0.99162946	.	0.4719	0.33344	1.912614283	97.42863883	1302.69006	6.79071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	208	chr16	55866900	chr16:55866900	T	C	88	PASS	AN=2;DP=208	GT	0/1
chr16	57015545	57015545	C	T	intronic	CETP	.	.	.	5.18E-12	0.191291722	0.808708278	DISEASE: Hyperalphalipoproteinemia 1 (HALP1) [MIM:143470]: A condition characterized by high levels of high density lipoprotein (HDL) and increased HDL cholesterol levels. {ECO:0000269|PubMed:12091484, ECO:0000269|PubMed:2215607, ECO:0000269|PubMed:8408659}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16082	0.36962	-0.064242613	48.844067	320.75729	3.80433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	77	chr16	57015545	chr16:57015545	C	T	87	PASS	AN=2;DP=77	GT	0/1
chr16	58312358	58312358	T	-	intronic	CCDC113	.	.	.	3.95E-13	0.023524609	0.976475391	.	0.05168	0.08022	-0.336073593	30.55555556	127.02556	2.45806	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.72	127	chr16	58312357	chr16:58312357	CT	C	18.72	PASS	AN=0;DP=127	GT	0/1
chr16	69996985	69996985	G	C	intronic	CLEC18A	.	.	.	0.144113695	0.778785582	0.077100722	.	.	.	.	.	3437.51904	11.25783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	339	chr16	69996985	chr16:69996985	G	C	119	PASS	AN=2;DP=339	GT	0/1
chr16	70693872	70693872	-	T	intronic	IL34	.	.	.	0.114215553	0.85818846	0.027595987	.	0.23864	0.07227	0.841481379	88.35810333	232.37986	3.29666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	95	chr16	70693872	chr16:70693872	C	CT	139	PASS	AN=2;DP=95	GT	0/1
chr16	88945792	88945792	C	T	exonic	CBFA2T3	.	synonymous SNV	CBFA2T3:NM_175931:exon10:c.G1290A:p.A430A,CBFA2T3:NM_005187:exon11:c.G1548A:p.A516A	0.454440082	0.54530519	0.000254728	DISEASE: Note=A chromosomal aberration involving CBFA2T3 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein. {ECO:0000269|PubMed:10995019, ECO:0000269|PubMed:11224496, ECO:0000269|PubMed:9596646}.; 	0.5017	0.1813	-1.015898037	8.144609578	345.59186	3.94358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	419	chr16	88945792	chr16:88945792	C	T	116	PASS	AN=2;DP=419	GT	0/1
chr16	89657510	89657510	C	T	intronic	CPNE7	.	.	.	1.63E-13	0.026868774	0.973131226	.	0.10022	.	-1.343026423	4.647322482	1754.91457	7.73074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	151	chr16	89657510	chr16:89657510	C	T	107	PASS	AN=2;DP=151	GT	0/1
chr17	5323631	5323631	A	G	intronic	RPAIN	.	.	.	6.36E-06	0.271529765	0.728463876	.	0.19849	.	-0.005381972	53.50908233	771.71707	5.49858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	81	chr17	5323631	chr17:5323631	A	G	79	PASS	AN=2;DP=81	GT	0/1
chr17	11840616	11840616	G	A	intronic	DNAH9	.	.	.	1.37E-35	0.999999244	7.56E-07	.	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	50	chr17	11840616	chr17:11840616	G	A	58	PASS	AN=2;DP=50	GT	0/1
chr17	16068463	16068463	C	T	exonic	NCOR1	.	nonsynonymous SNV	NCOR1:NM_001190438:exon2:c.G121A:p.G41R,NCOR1:NM_001190440:exon4:c.G448A:p.G150R,NCOR1:NM_006311:exon5:c.G448A:p.G150R	0.999999999	7.43E-10	7.08E-30	.	0.57767	0.62451	-2.137013188	1.49799481	297.95501	3.68236	0.012	0.546	D	0.569	0.689	P	0.071	0.588	B	0.022	0.266	N	0.840	0.350	D	1.04	0.263	L	0.93	0.441	T	-2.42	0.625	N	0.305	0.441	-0.944	0.421	T	0.156	0.488	T	.	.	.	4.658	0.624	24.5	0.979	0.362	0.893	0.494	D	c	0.255	0.320	0.004	0.104	0.707	0.730	0	5.04	0.672	2.271	0.428	0.847	0.346	1.000	0.715	1.000	0.888	13.205	0.590	N-CoR, GPS2-interacting domain	.	.	0.5	89	127	chr17	16068463	chr17:16068463	C	T	89	PASS	AN=2;DP=127	GT	0/1
chr17	21216846	21216846	G	C	exonic	MAP2K3	.	synonymous SNV	MAP2K3:NM_002756:exon11:c.G870C:p.L290L,MAP2K3:NM_145109:exon11:c.G957C:p.L319L,MAP2K3:NM_001316332:exon12:c.G870C:p.L290L	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	185	293	chr17	21216846	chr17:21216846	G	C	185	PASS	AN=2;DP=293	GT	0/1
chr17	33769060	33769060	C	G	exonic	SLFN13	.	nonsynonymous SNV	SLFN13:NM_144682:exon5:c.G1444C:p.E482Q	8.75E-15	0.004834494	0.995165506	.	0.05976	0.06727	2.763559657	98.99740505	1954.11134	8.1348	0.662	0.078	T	0.017	0.373	B	0.028	0.371	B	0.094	0.025	N	1	0.090	N	0.835	0.211	L	4.46	0.036	T	-0.29	0.132	N	0.097	0.098	-0.951	0.409	T	0.011	0.041	T	0.002	0.045	T	-0.534	0.054	0.181	0.165	0.004	0.020	0.060	N	c	-0.993	-1.083	0.000	0.070	0.707	0.730	0	0.85	0.180	-0.990	0.038	-0.600	0.044	0.000	0.063	0.000	0.016	4.176	0.097	.	.	.	0.5	102	520	chr17	33769060	chr17:33769060	C	G	102	PASS	AN=2;DP=520	GT	0/1
chr17	33849692	33849692	A	T	intergenic	SLFN12L;SLFN14	dist=34934;dist=25452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	217	chr17	33849692	chr17:33849692	A	T	96	PASS	AN=2;DP=217	GT	0/1
chr17	42336517	42336517	C	T	intronic	SLC4A1	.	.	.	0.909484295	0.090515465	2.40E-07	DISEASE: Ovalocytosis, Southeast Asian (SAO) [MIM:166900]: A hereditary hematologic disorder characterized by ovalocytic erythrocytes that are rigid and exhibit reduced expression of many erythrocyte antigens. Clinical manifestations include mild hemolysis, intermittent jaundice and gallstones. However, the disorder is most often asymptomatic. {ECO:0000269|PubMed:1538405, ECO:0000269|PubMed:1722314}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spherocytosis 4 (SPH4) [MIM:612653]: Spherocytosis is a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. {ECO:0000269|PubMed:10580570, ECO:0000269|PubMed:10745622, ECO:0000269|PubMed:10942416, ECO:0000269|PubMed:11380459, ECO:0000269|PubMed:1378323, ECO:0000269|PubMed:15813913, ECO:0000269|PubMed:16227998, ECO:0000269|PubMed:7530501, ECO:0000269|PubMed:8547122, ECO:0000269|PubMed:8640229, ECO:0000269|PubMed:8943874, ECO:0000269|PubMed:9012689, ECO:0000269|PubMed:9207478, ECO:0000269|PubMed:9233560, ECO:0000269|PubMed:9973643}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Renal tubular acidosis, distal, autosomal dominant (AD- dRTA) [MIM:179800]: An autosomal dominant disease characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha- intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Renal tubular acidosis, distal, with hemolytic anemia (dRTA-HA) [MIM:611590]: A disease characterized by the association of hemolytic anemia with distal renal tubular acidosis, the reduced ability to acidify urine resulting in variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. {ECO:0000269|PubMed:10926824, ECO:0000269|PubMed:15211439, ECO:0000269|PubMed:9854053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Renal tubular acidosis, distal, with normal red cell morphology (dRTA-NRC) [MIM:611590]: A disease characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha- intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification. {ECO:0000269|PubMed:15211439}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10965	0.57746	-0.789972689	12.61500354	702.26691	5.26999	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	401	chr17	42336517	chr17:42336517	C	T	58	PASS	AN=2;DP=401	GT	0/1
chr17	45234303	45234303	G	C	exonic	CDC27	.	nonsynonymous SNV	CDC27:NM_001293091:exon6:c.C635G:p.A212G,CDC27:NM_001114091:exon7:c.C818G:p.A273G,CDC27:NM_001256:exon7:c.C818G:p.A273G,CDC27:NM_001293089:exon7:c.C818G:p.A273G	0.486673202	0.513325147	1.65E-06	.	0.94354	0.15358	-0.117432389	44.89266336	13.5224	0.49131	0.018	0.512	D	0.304	0.429	B	0.15	0.359	B	0.000	0.559	D	1.000	0.537	D	2.075	0.572	M	-0.37	0.690	T	-1.4	0.366	N	0.54	0.598	-0.773	0.567	T	0.187	0.538	T	.	.	.	2.860	0.404	21.7	0.968	0.306	0.989	0.890	D	c	0.310	0.470	1.0	0.983	0.716	0.820	0	5.64	0.864	9.384	0.966	0.998	0.613	1.000	0.715	0.997	0.653	17.208	0.867	.	.	.	0.5	86	61	chr17	45234303	chr17:45234303	G	C	86	PASS	AN=2;DP=61	GT	0/1
chr17	45669359	45669359	T	G	exonic	NPEPPS	.	nonsynonymous SNV	NPEPPS:NM_006310:exon11:c.T1298G:p.F433C,NPEPPS:NM_001330257:exon12:c.T1286G:p.F429C	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.65	0.994	H	2.93	0.098	T	-7.52	0.960	D	0.708	0.991	-0.296	0.751	T	0.186	0.537	T	.	.	.	6.465	0.892	29.9	0.994	0.647	0.983	0.810	D	c	1.055	0.941	1.000	0.747	0.732	0.924	0	5.51	0.817	7.834	0.848	0.875	0.382	1.000	0.715	1.000	0.888	15.626	0.765	Peptidase M1, membrane alanine aminopeptidase, N-terminal	.	.	0.5	95	134	chr17	45669359	chr17:45669359	T	G	95	PASS	AN=2;DP=134	GT	0/1
chr18	49208	49208	G	A	intergenic	LOC102723376;ROCK1P1	dist=33278;dist=59857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.25	0.791	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.269	0.120	5.391	0.711	0.092	0.191	0.203	N	n	-0.126	-0.174	0.000	0.012	0.554	0.283	0	0.109	0.138	-0.406	0.072	0.344	0.273	0.844	0.301	0.001	0.043	2.943	0.054	.	.	.	0.5	142	207	chr18	49208	chr18:49208	G	A	142	PASS	AN=2;DP=207	GT	0/1
chr19	15918201	15918201	A	G	exonic	OR10H1	.	nonsynonymous SNV	OR10H1:NM_013940:exon1:c.T647C:p.L216P	0.637065116	0.334487775	0.028447109	.	0.15432	0.095	0.575097644	82.1656051	2707.23222	9.78935	0.008	0.586	D	0.997	0.689	D	0.976	0.719	D	0.012	0.295	N	0.937	0.372	D	3.125	0.882	M	8.34	0.003	T	-4.7	0.798	D	0.67	0.680	-0.686	0.611	T	0.002	0.006	T	0.005	0.127	T	4.839	0.650	24.8	0.999	0.930	0.163	0.191	N	c	0.497	0.355	0.001	0.086	0.487	0.133	0	4.96	0.650	2.769	0.471	0.897	0.411	0.014	0.188	0.989	0.536	12.564	0.555	GPCR, rhodopsin-like, 7TM	.	.	0.5	126	185	chr19	15918201	chr19:15918201	A	G	126	PASS	AN=2;DP=185	GT	0/1
chr19	21608502	21608502	A	G	UTR3	ZNF493	NM_175910:c.*716A>G;NM_001076678:c.*716A>G	.	.	3.19E-08	0.517403821	0.482596148	.	0.19726	.	-0.372889896	28.20240623	184.42675	2.94725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	43	chr19	21608502	chr19:21608502	A	G	59	PASS	AN=2;DP=43	GT	0/1
chr19	33490585	33490585	G	A	exonic	RHPN2	.	stopgain	RHPN2:NM_033103:exon10:c.C1132T:p.Q378X	0.000336631	0.997287291	0.002376078	.	0.1907	0.10228	0.003714825	54.06935598	5254.99892	14.95444	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.292	0.982	39	0.998	0.910	0.991	0.907	D	c	1.043	0.881	1.000	0.747	0.672	0.522	0	4.72	0.591	9.105	0.935	0.889	0.393	1.000	0.715	0.979	0.486	17.685	0.881	BRO1 domain	.	.	0.5	138	193	chr19	33490585	chr19:33490585	G	A	138	PASS	AN=2;DP=193	GT	0/1
chr19	40368733	40368733	G	C	exonic	FCGBP	.	synonymous SNV	FCGBP:NM_003890:exon28:c.C12615G:p.L4205L	.	.	.	.	0.54275	.	.	.	18359.5916	28.93384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	153	753	chr19	40368733	chr19:40368733	G	C	153	PASS	AN=2;DP=753	GT	0/1
chr19	51274851	51274851	A	C	exonic	GPR32	.	nonsynonymous SNV	GPR32:NM_001506:exon1:c.A994C:p.T332P	7.91E-05	0.315038766	0.68488214	.	0.0893	.	0.108486928	61.90728946	99.68741	2.16289	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-1.72	0.003	N	1.24	0.367	T	3.88	0.001	N	0.074	0.064	-0.995	0.312	T	0.030	0.131	T	.	.	.	-1.311	0.022	0.004	0.827	0.139	0.001	0.005	N	c	-1.513	-1.493	0.002	0.089	0.497	0.185	0	-0.781	0.104	0.074	0.144	-0.869	0.028	0.000	0.063	0.757	0.323	3.651	0.077	.	.	.	0.5	94	74	chr19	51274851	chr19:51274851	A	C	94	PASS	AN=2;DP=74	GT	0/1
chr19	51919120	51919120	A	G	UTR5	LOC100129083	NM_001256795:c.-159A>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	234	chr19	51919120	chr19:51919120	A	G	145	PASS	AN=2;DP=234	GT	0/1
chr19	53990021	53990021	A	G	intronic	ZNF813	.	.	.	8.50E-10	0.079646859	0.92035314	.	0.08121	.	1.35769336	94.43854683	2208.34827	8.65139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	176	208	chr19	53990021	chr19:53990021	A	G	176	PASS	AN=2;DP=208	GT	0/1
chr19	58420660	58420660	T	C	exonic	ZNF417	.	nonsynonymous SNV	ZNF417:NM_001297734:exon3:c.A983G:p.Y328C,ZNF417:NM_152475:exon3:c.A986G:p.Y329C	1.13E-06	0.566466254	0.433532618	.	0.098	0.07895	0.887394731	89.18966737	527.71827	4.68764	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	0.973	0.265	N	-3.59	0.000	N	6.56	0.006	T	10.24	0.000	N	0.185	0.232	-0.966	0.381	T	0.000	0.001	T	0.001	0.017	T	-1.318	0.022	0.004	0.051	0.000	0.007	0.030	N	c	-1.699	-1.547	0.632	0.220	0.707	0.730	0	1.12	0.196	2.653	0.461	-0.256	0.089	0.993	0.376	0.017	0.128	7.822	0.283	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	81	74	chr19	58420660	chr19:58420660	T	C	81	PASS	AN=2;DP=74	GT	0/1
chr20	29625873	29625873	A	C	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	0.002	0.721	D	0.837	0.444	P	0.783	0.556	P	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	-2.77	0.587	D	0.799	0.789	-0.879	0.499	T	0.181	0.529	T	.	.	.	3.765	0.509	23.4	0.993	0.591	0.844	0.432	D	c	0.345	0.056	0.999	0.397	0.675	0.547	0	1.68	0.231	1.417	0.342	0.675	0.295	1.000	0.715	0.098	0.188	7.376	0.258	Actin cross-linking	.	.	0.5	142	166	chr20	29625873	chr20:29625873	A	C	142	PASS	AN=2;DP=166	GT	0/1
chr20	29632570	29632571	AG	-	ncRNA_intronic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	140	chr20	29632569	chr20:29632569	CAG	C	96	PASS	AN=2;DP=140	GT	0/1
chr20	29632612	29632614	AAG	-	ncRNA_exonic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	226	chr20	29632611	chr20:29632611	AAAG	A	83	PASS	AN=2;DP=226	GT	0/1
chr20	29637851	29637851	C	G	ncRNA_exonic	MLLT10P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	148	chr20	29637851	chr20:29637851	C	G	106	PASS	AN=2;DP=148	GT	0/1
chr20	43976991	43976991	A	G	exonic	SDC4	.	nonsynonymous SNV	SDC4:NM_002999:exon1:c.T34C:p.F12L	0.011803491	0.847335334	0.140861176	.	0.26113	0.20685	-0.161524709	41.6430762	2463.14431	9.23969	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.354	0.043	N	1	0.588	P	-1.905	0.002	N	1.72	0.266	T	1.24	0.010	N	0.044	0.024	-0.934	0.436	T	0.000	0.000	T	.	.	.	1.585	0.252	13.77	0.784	0.119	0.065	0.124	N	c	-1.092	-0.869	1.000	0.747	0.564	0.319	0	1.9	0.247	0.261	0.181	0.088	0.194	0.995	0.385	0.796	0.335	5.835	0.177	.	.	.	0.5	165	182	chr20	43976991	chr20:43976991	A	G	165	PASS	AN=2;DP=182	GT	0/1
chr20	46294828	46294828	T	C	intronic	SULF2	.	.	.	0.878046241	0.121953654	1.05E-07	.	0.1472	.	-1.591018721	3.084453881	835.17771	5.65739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	223	chr20	46294828	chr20:46294828	T	C	132	PASS	AN=2;DP=223	GT	0/1
chr20	46294864	46294864	A	G	intronic	SULF2	.	.	.	0.878046241	0.121953654	1.05E-07	.	0.1472	.	-1.591018721	3.084453881	835.17771	5.65739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	204	chr20	46294864	chr20:46294864	A	G	139	PASS	AN=2;DP=204	GT	0/1
chr20	56834807	56834807	C	T	ncRNA_intronic	PPP4R1L	.	.	.	.	.	.	.	.	.	.	.	1076.00834	6.28755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	140	chr20	56834807	chr20:56834807	C	T	84	PASS	AN=2;DP=140	GT	0/1
chr21	11049623	11049623	T	C	splicing	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:exon4:c.280-2A>G;NM_182481:exon4:c.280-2A>G;NM_181704:exon4:c.285-2A>G;NM_181704:exon4:UTR3;NM_182484:exon4:c.284-2A>G;NM_182484:exon4:UTR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	155	chr21	11049623	chr21:11049623	T	C	94	PASS	AN=2;DP=155	GT	0/1
chr21	45970993	45970993	C	G	exonic	KRTAP10-2	.	nonsynonymous SNV	KRTAP10-2:NM_198693:exon1:c.G349C:p.A117P	0.017072106	0.71341424	0.269513654	.	0.10939	.	0.971952656	90.26893135	2694.09373	9.76825	0.684	0.044	T	0.89	0.470	P	0.293	0.390	B	.	.	.	1.000	0.090	P	1.495	0.376	L	5.85	0.007	T	0.12	0.056	N	0.05	0.034	-1.108	0.032	T	0.000	0.000	T	.	.	.	-0.654	0.047	0.093	0.611	0.065	0.017	0.053	N	c	-1.156	-1.281	1.000	0.473	0.609	0.351	0	0.117	0.139	-4.321	0.003	-3.150	0.001	0.000	0.063	0.000	0.016	6.221	0.198	.	.	.	0.5	103	135	chr21	45970993	chr21:45970993	C	G	103	PASS	AN=2;DP=135	GT	0/1
chr22	21363782	21363782	G	A	ncRNA_exonic	THAP7-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	189	chr22	21363782	chr22:21363782	G	A	.	PASS	AN=0;DP=189	GT	0/1
chr22	50312802	50312818	CCCTCGACCTGGGCTCG	-	intronic	CRELD2	.	.	.	4.96E-08	0.220198053	0.779801898	.	0.23727	0.10908	0.801024817	87.65628686	1620.87519	7.44658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	166	126	chr22	50312801	chr22:50312801	ACCCTCGACCTGGGCTCG	A	166	PASS	AN=2;DP=126	GT	0/1
chr22	51193798	51193798	G	A	intergenic	ACR;RPL23AP82	dist=10071;dist=1716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	496	chr22	51193798	chr22:51193798	G	A	138	PASS	AN=2;DP=496	GT	0/1
chrX	106296453	106296453	A	T	intergenic	MORC4;RBM41	dist=52979;dist=8665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	171	chrX	106296453	chrX:106296453	A	T	124	PASS	AN=2;DP=171	GT	0/1
chrX	114953359	114953359	C	T	intergenic	PLS3;DANT2	dist=68180;dist=3370	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	174	chrX	114953359	chrX:114953359	C	T	65	PASS	AN=2;DP=174	GT	0/1
chrX	129354266	129354266	C	A	intronic	ZNF280C	.	.	.	0.992273042	0.007726643	3.15E-07	.	0.1424	.	-0.492218069	22.35786742	14.15249	0.5125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	87	chrX	129354266	chrX:129354266	C	A	64	PASS	AN=2;DP=87	GT	0/1
